390 Novel strategies combining PI3K/mTOR inhibitors with autophagy modulators, metabolic disruptors, or immune-targeting agents are currently being tested in preclinical and early clinical trials
Head to mikereinold.com, click on the podcast link, and you can submit questions for future episodes
AOD-9604 Administration Guide Proper administration technique ensures optimal absorption, minimizes discomfort, and maintains the peptides stability and efficacy
Weve focused on alcohol after surgery, but what about the other side of the coin
09What safety risk does the telomerase-cancer paradox pose
Biochim Biophys Acta Mol Cell Res 1499:144153 Robbins AH, McRhee DE, Williamson M, Collett SA, Xuong NH, Furey WF, Wang BC, Stout CD (1991) Refined crystal structure of Cd,Zn metallothionein at 2.0 resolution